Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Revenue From Contracts With Customers - Disaggregation of Revenue (Details)

v3.19.3
Note 3 - Revenue From Contracts With Customers - Disaggregation of Revenue (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue from contract with customer $ 5,000 $ 22,000 $ 35,000 $ 303,000
Royalty [Member]        
Revenue from contract with customer 4,895 2,382 13,985 9,842
Royalty [Member] | Diagnostics Segment [Member]        
Revenue from contract with customer 4,895 2,382 13,985 9,842
NAV4694 Sublicense [Member] | Diagnostics Segment [Member]        
Revenue from contract with customer   14,930   272,639
License [Member]        
Revenue from contract with customer 19,930 9,953 277,639
License [Member] | Diagnostics Segment [Member]        
Revenue from contract with customer   19,930 9,953 277,639
Product and Service, Other [Member] | Diagnostics Segment [Member]        
Revenue from contract with customer     11,024 15,037
Europe [Member] | Royalty [Member] | Diagnostics Segment [Member]        
Revenue from contract with customer $ 4,895 2,382 $ 13,985 9,842
CHINA | Expanded Tc99m Tilmanocept License Agreement [Member] | Diagnostics Segment [Member]        
Revenue from contract with customer   $ 5,000   $ 5,000